LifeStance Health Group, Inc.
NASDAQ:LFSTMedical - Care Facilities
+$0.17 today
- Market cap
- $5.24B
- Beta
- 1.19
- P/E (TTM)
- 146.6
- EPS (TTM)
- $0.06
Volume 6.60M
Average 3.91M
LFST Account Payables
Amounts the company owes suppliers for goods and services received.
LifeStance Health Group, Inc.NASDAQ: LFST
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables rises 41.9% from a year ago
Account payables stood at $11.05M at the end of Q2 FY2026, up 41.9% from a year earlier and up 157.5% from the prior quarter. Over 3 fiscal years it compounded at -36.9% a year.
Context
- Account payables amounted to 0.5% of total assets at the end of Q2 FY2026, up 0.1 pp from a year earlier.
- Account payables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +41.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 6.12M USD
- Year-over-year change
- -15.5%
- 4-year CAGR
- -18.9%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.12M | -15.5% |
| FY2024 | 2024-12-31 | 7.24M | -68.8% |
| FY2023 | 2023-12-31 | 23.21M | -4.8% |
| FY2022 | 2022-12-31 | 24.37M | +72.2% |
| FY2021 | 2021-12-31 | 14.15M | — |
Account Payables vs competitors
How LFST compares with its peers on the latest reported figures
- LFST's Jun 2026 account payables of $11.05M is the lowest of the 7 companies compared; the peer median is $532.78M.
- Its year-over-year change of +41.9% is the 3rd highest of 7, against a peer median of +33.6%.
- Account payables amounts to 0.5% of total assets for LFST, versus a peer median of 17.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.45B | +11.5% | +5.6% | 15.4% | |
| Sep 2026 | $1.23B | +29.1% | +32.2% | 19.7% | |
| Jun 2026 | $549.86M | +6000.1% | +5.8% | 36.9% | |
| Sep 2026 | $515.69M | +159.9% | +64.2% | 14.5% | |
| Sep 2026 | $138.56M | -23.0% | +12.8% | 2.5% | |
| Mar 2026 | $21.65M | +38.1% | +11.9% | 30.9% | |
| Jun 2026 | $11.05M | +41.9% | -36.9% | 0.5% | |
| Peer median (excluding LFST) | $532.78M | +33.6% | +12.3% | 17.5% | |
Competitors are the stored peer set for LFST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 148.03M | 108.62M | 78.82M | 154.57M | 248.64M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 99.31M | 101.51M | 125.64M | 132.03M | 95.71M |
| Inventory | 38.07M | 0 | 0 | 0 | 0 |
| Other Current Assets | (25.72M) | 11M | 10.73M | 14.9M | 71.85M |
| Total Current Assets | 266.52M | 233.22M | 225.73M | 312.51M | 416.2M |
| Property, Plant & Equipment (Net) | 152.24M | 393.62M | 358.93M | 313.92M | 311.3M |
| Goodwill | 1.2B | 1.27B | 1.29B | 1.29B | 1.29B |
| Intangible Assets | 300.36M | 263.29M | 221.07M | 190.8M | 177.67M |
| Long-term Investments | (42.56M) | 0 | 0 | 0 | 0 |
| Tax Assets | 42.56M | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3.45M | 10.8M | 10.9M | 7.72M | 5.42M |
| Total Non-current Assets | 1.66B | 1.94B | 1.88B | 1.81B | 1.79B |
| Total Assets | 1.93B | 2.17B | 2.11B | 2.12B | 2.2B |
| Account Payables | 14.15M | 24.37M | 23.21M | 7.24M | 6.12M |
| Short-term Debt | 1.32M | 2.35M | 2.93M | 7.25M | 45.54M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 76.06M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (50.83M) | 16.47M | 8.93M | 18.98M | 200.3M |
| Total Current Liabilities | 116.75M | 176M | 202.87M | 228.89M | 251.96M |
| Long-term Debt | 157.42M | 225.08M | 280.29M | 279.79M | 148.55M |
| Deferred Tax Liabilities | 54.28M | 38.7M | 15.57M | 14.33M | 16.41M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 53.63M | 2.78M | 952K | 309K | 266M |
| Total Non-current Liabilities | 265.33M | 479.15M | 478.17M | 443.13M | 430.96M |
| Total Liabilities | 382.08M | 655.15M | 681.04M | 672.01M | 682.92M |
| Common Stock | 3.74M | 3.76M | 3.79M | 3.83M | 3.88M |
| Retained Earnings | (357.07M) | (572.64M) | (760.85M) | (818.29M) | (808.63M) |
| Accumulated OCI | 0 | 3.27M | 2.3M | 929K | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.55B | 1.52B | 1.43B | 1.45B | 1.52B |
| Total Debt | 158.74M | 478.83M | 511.04M | 485.19M | 194.1M |
| Net Debt | 10.71M | 370.21M | 432.22M | 330.62M | (54.55M) |
LifeStance Health Group, Inc.
NASDAQ:LFST
Intrinsic Alpha fair value
Locked
Current Price
$13.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.